-
Todos Medical Receipt Notice of Allowance from USPTO for 3CL Protease Inhibitor Dietary Supplement Tollovid(TM)
[ad_1] New York, NY, and Tel Aviv, ISRAEL – (NewMediaWire) – August 5, 2021 – Todos Medical, Ltd. (OTCQB: TOMDF), a…
Read More » -
News
NutraLife Biosciences Inc. (NLBS) Announces the Company’s Financial Fully Reporting Status
[ad_1] Coconut Creek, FL – (NewMediaWire) – August 5, 2021 – NutraLife Biosciences, Inc. (“NutraLife” or the “Company”) (OTC: NLBS)…
Read More » -
Paltalk, Inc. Announces Closing of $4.0 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option
[ad_1] JERICHO, NY – (NewMediaWire) – August 05, 2021 – Paltalk, Inc. (“Paltalk,” the “Company,” “we,” “our” or “us”) (Nasdaq:…
Read More » -
Nephros Announces Results for Quarter Ended June 30, 2021
[ad_1] Second Quarter Net Revenue of $2.3 Million; 44% Year-Over-Year Increase; Strategic Acquisition of GenArraytion, Inc.; HDF Product Submitted to…
Read More » -
News
Nunzia Pharmaceutical Corporation (OTC:NUNZ), an Emerging Leader in Innovative Pharmaceutical and Nutraceuticals, has Signed a Licensing Agreement with Michael Mitsunaga for the Exclusive Patent Rights to his IV BLOOD WARMER
[ad_1] San Clemente, CA – (NewMediaWire) – August 06, 2021 – Nunzi Pharmaceutical Corporation (OTC:NUNZ) entered into a License Agreement…
Read More »